EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hormonal Treatment of Endometriosis: A Narrative Review

Elvin Piriyev iD, Sven Schiermeier, Thomas Römer

Pharmaceuticals · 17.04.2025 · 18 (4) · 588

DOI: 10.3390/ph18040588 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 17.04.2025. Verfasst von Elvin Piriyev und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Gynecology and Obstetrics, University Witten-Herdecke, 58455 Witten, Germany. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endometriosis is one of the most common gynecological diseases, affecting up to 10–15% of women of reproductive age. It is a chronic, estrogen-dependent condition that often presents with heterogeneous symptoms, complicating diagnosis and delaying treatment.

Methods

This is a narrative review based on a comprehensive analysis of recent literature regarding hormonal treatment options for endometriosis, including primary and adjuvant therapies.

Results

Combined oral contraceptives (COCs) are effective in reducing dysmenorrhea, but show limited benefit for other symptoms and may not prevent disease progression. Progestins, particularly dienogest, demonstrate superior long-term efficacy with favorable side-effect profiles. GnRH agonists and antagonists are reserved for second-line treatment due to side effects and hypoestrogenism, but can significantly reduce endometriotic lesions. The levonorgestrel intrauterine system (LNG-IUS) is especially effective in patients with adenomyosis.

Conclusions

Hormonal therapies are central to the management of endometriosis. Progestins are considered the most suitable long-term option. Despite promising results, evidence quality varies, and further studies are needed to establish long-term efficacy, patient-specific outcomes, and direct comparisons between agents.

Schlagwörter

Stichwörter der Autor:innen

GnRH agonistsGnRH antagonistscombined oral contraceptiveendometriosishormonal treatmentnarrative reviewprogestins

Autor:innen und Institutionen

  • Chair of Gynecology and Obstetrics, University Witten-Herdecke, 58455 Witten, Germany.
  • Department of Obstetrics and Gynecology, Academic Hospital Cologne Weyertal, University of Cologne, Weyertal 76, 50931 Cologne, Germany.
  • Chair of Gynecology and Obstetrics, University of Cologne, 50923 Cologne, Germany.

ORCID-Profile: Elvin Piriyev

Zitieren

APA

Piriyev, E., Schiermeier, S., & Römer, T. (2025). Hormonal Treatment of Endometriosis: A Narrative Review. Pharmaceuticals, 18(4), 588. https://doi.org/10.3390/ph18040588

Vancouver

Piriyev E, Schiermeier S, Römer T. Hormonal Treatment of Endometriosis: A Narrative Review. Pharmaceuticals. 2025;18(4):588. doi:10.3390/ph18040588

BibTeX
@article{Piriyev2025,
  author = {Piriyev, Elvin and Schiermeier, Sven and Römer, Thomas},
  title = {Hormonal Treatment of Endometriosis: A Narrative Review},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {4},
  pages = {588},
  doi = {10.3390/ph18040588}
}
Kostenlos starten →